In our group of overweight and obese pregnant women, MVPA was associated with
improved insulin sensitivity, insulin response, and decreased triglycerides at 32 weeks of pregnancy.
This supports efforts for counseling obese women at risk for gestational diabetes in pregnancy
to maintain their MVPA levels.